AMZN
Amazon.com, Inc.
AMZN has the edge over CULP overall, supported by stronger valuation and stronger modeled upside.
CULP
Culp, Inc.
CULP trails on the overall score without a compensating advantage in the available component scores.
AMZN Fundamentals
| Metric | Status |
|---|---|
| Healthy | |
| Healthy | |
| Weak | |
| Healthy |
AMZN's revenue, profitability and balance sheet are currently healthy, but its cash flow is weak.
CULP Fundamentals
| Metric | Status |
|---|---|
| Stable | |
| Stable | |
| Under pressure | |
| Weak |
CULP's revenue and profitability are currently stable, but its cash flow and balance sheet are under pressure.
AMZN PE Valuation
| Level | PE | Price | Vs current |
|---|---|---|---|
| Current | 22x | $267 | — |
| Forward | 27x | $267 | — |
| Cheap | 34x | $415 | +55% |
| Fair | 60x | $745 | +179% |
| Expensive | 102x | $1,262 | +372% |
Historical ranges are pointers, not guarantees.
AMZN's PE is in its cheap range at 22x, but its recent earnings include one-off gains. On analysts' estimates for next year's earnings, today's price would be 27x.
CULP PE Valuation
CULP has no meaningful PE right now: it lost money over the past year.
AMZN Forward outlook
| Metric | Outlook |
|---|---|
| Strongly deteriorating | |
| Strong growth | |
| Growth | |
| Improving | |
| Moderate | |
| Moderate |
Analysts expect earnings and revenue growth for AMZN, with profitability improving.
CULP Forward outlook
| Metric | Outlook |
|---|---|
| -- | |
| Turning to a loss | |
| Stable | |
| -- | |
| Limited | |
| -- |
Analysts expect CULP's earnings to decline, with its revenue and profitability holding steady.
AMZN Earnings Per Share
| Quarter | TTM EPS | YoY |
|---|---|---|
| Forward | $9.87 | -20% |
| Q3 2026 | $12.37 | +75% |
| Q2 2026 | $12.43 | +89% |
| Q1 2026 | $8.36 | +36% |
| Q4 2025 | $7.17 | +30% |
| Q3 2025 | $7.08 | +52% |
| Q2 2025 | $6.56 | +57% |
| Q1 2025 | $6.14 | +72% |
| Q4 2024 | $5.53 | +91% |
AMZN has the edge over CULP on earnings quality, reporting a profit while its opponent remains loss making.
CULP Earnings Per Share
| Quarter | TTM EPS | YoY |
|---|---|---|
| Q3 2026 | -$0.32 | +$0.65 |
| Q2 2026 | -$0.81 | +$0.72 |
| Q1 2026 | -$0.80 | +$0.95 |
| Q4 2025 | -$0.86 | +$0.82 |
| Q3 2025 | -$0.97 | +$0.45 |
| Q2 2025 | -$1.53 | -$0.42 |
| Q1 2025 | -$1.75 | -$0.65 |
| Q4 2024 | -$1.68 | -$0.11 |
CULP is still losing money, but far less than before: $0.32 per share over the past year, against $2.68 at its worst in early 2023.
AMZN Quarterly Revenue
| Quarter | Revenue | YoY |
|---|---|---|
| Q3 2026 | $201.9B | +12% |
| Q2 2026 | $200.6B | +20% |
| Q1 2026 | $181.5B | +17% |
| Q4 2025 | $213.4B | +14% |
| Q3 2025 | $180.2B | +13% |
| Q2 2025 | $167.7B | +13% |
| Q1 2025 | $155.7B | +8.6% |
| Q4 2024 | $187.8B | +10% |
AMZN has the edge over CULP on sales, with more consistent year-over-year improvement.
| Quarter | Margin | YoY |
|---|---|---|
| Q3 2026 | 14% | +4.2 points |
| Q2 2026 | 14% | +2.3 points |
| Q1 2026 | 13% | +1.3 points |
| Q4 2025 | 12% | +0.4 points |
| Q3 2025 | 9.7% | -1.3 points |
| Q2 2025 | 11% | +1.5 points |
| Q1 2025 | 12% | +1.1 points |
| Q4 2024 | 11% | +3.5 points |
AMZN has the edge over CULP on profitability, with a higher operating margin.
CULP Quarterly Revenue
| Quarter | Revenue | YoY |
|---|---|---|
| Q3 2026 | $54M | +6.5% |
| Q2 2026 | $51.6M | +5.8% |
| Q1 2026 | $48M | -8.2% |
| Q4 2025 | $53.2M | -4.4% |
| Q3 2025 | $50.7M | -10% |
| Q2 2025 | $48.8M | -1.5% |
| Q1 2025 | $52.3M | -14% |
| Q4 2024 | $55.7M | -5.2% |
CULP's revenue is recovering but still below its 2021 peak: $54M last quarter, up 6.5% from the same quarter a year ago.
| Quarter | Margin | YoY |
|---|---|---|
| Q3 2026 | 12% | +9.2 points |
| Q2 2026 | -3.1% | +1.4 points |
| Q1 2026 | -7.8% | -0.3 points |
| Q4 2025 | -6.5% | +3.2 points |
| Q3 2025 | 3.2% | +15 points |
| Q2 2025 | -4.6% | +4 points |
| Q1 2025 | -7.4% | -4.6 points |
| Q4 2024 | -9.7% | -5.9 points |
CULP's operating margin was 12% last quarter, up 9.2 points from the same quarter a year ago, near the top of its range since 2019.
AMZN Free Cash Flow
| Quarter | Free cash flow | YoY |
|---|---|---|
| Q3 2026 | -$34.8B | -8202% |
| Q2 2026 | -$8.8B | -2757% |
| Q1 2026 | -$18.2B | -$10.2B |
| Q4 2025 | $14.9B | -16% |
| Q3 2025 | $430M | -87% |
| Q2 2025 | $332M | -96% |
| Q1 2025 | -$8B | -297% |
| Q4 2024 | $17.8B | -36% |
AMZN's free cash flow was −$46.9B over the past year, against $10.6B the year before.
CULP Free Cash Flow
| Quarter | Free cash flow | YoY |
|---|---|---|
| Q3 2026 | $7.8M | +$8.7M |
| Q2 2026 | -$7.3M | +$1.5M |
| Q1 2026 | -$1.3M | +$6.3M |
| Q4 2025 | -$510K | +$3M |
| Q3 2025 | -$874K | -$167K |
| Q2 2025 | -$8.7M | -$6M |
| Q1 2025 | -$7.7M | -$4.9M |
| Q4 2024 | -$3.5M | -$2M |
CULP has the edge over AMZN on cash flow, with more consistent year-over-year improvement.
AMZN Total Shares
| Period | Change % | Net change |
|---|---|---|
| Quarterly | +0.2% | +26M shares |
| 1 year | +0.8% | +84M shares |
| 3 years | +3.5% | +371M shares |
| 5 years | +6.1% | +629M shares |
| Available history | +8.2% | +829M shares |
AMZN has the edge over CULP on shareholder dilution, with a more favorable share count trend.
| Quarter | Spent |
|---|---|
| Q1 2024 | — |
| Q4 2023 | — |
| Q3 2023 | — |
| Q2 2023 | — |
| Q1 2023 | — |
| Q4 2022 | — |
| Q3 2022 | — |
| Q2 2022 | $3.3B |
CULP Total Shares
| Period | Change % | Net change |
|---|---|---|
| Quarterly | +1.5% | +191K shares |
| 1 year | +2% | +251K shares |
| 3 years | +4% | +489K shares |
| 5 years | +3.3% | +406K shares |
| Available history | +3.3% | +413K shares |
CULP has 13M diluted shares, up 2% from a year ago.
| Quarter | Spent |
|---|---|
| Q2 2022 | — |
| Q1 2022 | — |
| Q4 2021 | $1M |
| Q3 2021 | $723,000 |
| Q2 2020 | $952,000 |
AMZN Net Leverage
| Quarter | Net Leverage | Status |
|---|---|---|
| Q3 2026 | 0.7x | Very low |
| Q2 2026 | 0.3x | Very low |
| Q1 2026 | 0.1x | Very low |
| Q4 2025 | -0.1x | Net Cash |
| Q3 2025 | -0.1x | Net Cash |
| Q2 2025 | -0.0x | Net Cash |
| Q1 2025 | -0.1x | Net Cash |
| Q4 2024 | -0.2x | Net Cash |
AMZN has the edge over CULP on leverage, with a lower net debt burden relative to earnings.
CULP Net Leverage
| Quarter | Net Leverage | Status |
|---|---|---|
| Q3 2026 | 9.3x | High |
| Q2 2022 | -1.9x | Net Cash |
| Q1 2022 | -0.8x | Net Cash |
| Q4 2021 | -1.0x | Net Cash |
| Q3 2021 | -1.3x | Net Cash |
| Q1 2020 | -1.9x | Net Cash |
| Q4 2019 | -2.3x | Net Cash |
CULP's net debt is about 9.3 years of its operating earnings (EBITDA), after holding more cash than debt a year ago.
AMZN Weekly Momentum
| Metric | Value | Status |
|---|---|---|
| RSI | 57.1 | Neutral |
| Stochastic | 50.0 | Neutral |
AMZN's weekly RSI is 57 (neutral) and its Stochastic is 50 (neutral).
CULP Weekly Momentum
| Metric | Value | Status |
|---|---|---|
| RSI | 49.7 | Neutral |
| Stochastic | 34.1 | Neutral |
CULP's weekly RSI is 50 (neutral) and its Stochastic is 34 (neutral).
AMZN PE vs Consumer Cyclical Sector
| Metric | AMZN | Sector median | Relative |
|---|---|---|---|
| PE | 22x | 18x | 20% above |
| PE % | 4 | 47 | 43 pts below |
AMZN is trading at 22x earnings, a 20% premium to the Consumer Cyclical sector's median of 18x, though its recent earnings include one-off gains.
CULP PE vs Consumer Cyclical Sector
| Metric | CULP | Sector median | Relative |
|---|---|---|---|
| PE | N/A | 18x | — |
CULP has no meaningful PE right now: it lost money over the past year.
AMZN Weekly Moving Averages
| Moving average | MA price | Relative |
|---|---|---|
| 8 week MA | $253.6 | 5.5% above |
| 20 week MA | $254.9 | 4.9% above |
| 50 week MA | $242.5 | 10% above |
| 100 week MA | $229.6 | 17% above |
| 200 week MA | $191.4 | 40% above |
AMZN has the edge over CULP on trend strength, trading above more of its moving averages.
CULP Weekly Moving Averages
| Moving average | MA price | Relative |
|---|---|---|
| 8 week MA | $3.62 | 3.6% below |
| 20 week MA | $3.54 | 1.4% below |
| 50 week MA | $3.39 | 2.9% above |
| 100 week MA | $3.95 | 12% below |
| 200 week MA | $4.56 | 23% below |
CULP's trend is mixed: it's above one of its five weekly moving averages, and 23% below its 200-week average.
AMZN Yearly ROI
| Year | Start price | End price | ROI |
|---|---|---|---|
| 2020 | $93.5 | $158.6 | +70% |
| 2021 | $158.6 | $171.1 | +7.8% |
| 2022 | $171.1 | $85.3 | -50% |
| 2023 | $85.3 | $151.9 | +78% |
| 2024 | $151.9 | $223.8 | +47% |
| 2025 | $223.8 | $232.5 | +3.9% |
| 2026 YTD | $232.5 | $267.4 | +15% |
AMZN has the edge over CULP on returns for 2026, with the stronger performance.
CULP Yearly ROI
| Year | Start price | End price | ROI |
|---|---|---|---|
| 2020 | $14.2 | $15.6 | +9.9% |
| 2021 | $15.6 | $8.97 | -42% |
| 2022 | $8.97 | $4.63 | -48% |
| 2023 | $4.63 | $5.79 | +25% |
| 2024 | $5.79 | $5.86 | +1.2% |
| 2025 | $5.86 | $3.50 | -40% |
| 2026 YTD | $3.50 | $3.49 | -0.3% |
CULP has finished lower in three of the last six years. It's roughly flat so far in 2026.